{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T23:59:45Z","timestamp":1781135985810,"version":"3.54.1"},"reference-count":62,"publisher":"Informa UK Limited","issue":"5","funder":[{"DOI":"10.13039\/100000200","name":"USAID","doi-asserted-by":"publisher","award":["AID-OAA-A-16-00045"],"award-info":[{"award-number":["AID-OAA-A-16-00045"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["The European Journal of Contraception & Reproductive Health Care"],"published-print":{"date-parts":[[2018,9,3]]},"DOI":"10.1080\/13625187.2018.1508650","type":"journal-article","created":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T14:16:48Z","timestamp":1537798608000},"page":"326-334","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":18,"title":["A strategic action framework for multipurpose prevention technologies combining contraceptive hormones and antiretroviral drugs to prevent pregnancy and HIV"],"prefix":"10.1080","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7521-7085","authenticated-orcid":false,"given":"Bethany","family":"Young Holt","sequence":"first","affiliation":[{"name":"The Initiative for Multipurpose Prevention Technologies, Public Health Institute, Sacramento, CA, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7187-4379","authenticated-orcid":false,"given":"Laura","family":"Dellplain","sequence":"additional","affiliation":[{"name":"The Initiative for Multipurpose Prevention Technologies, Public Health Institute, Sacramento, CA, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5967-8180","authenticated-orcid":false,"given":"Mitchell D.","family":"Creinin","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of California, Davis, Sacramento, CA, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6153-3615","authenticated-orcid":false,"given":"Kevin J.","family":"Peine","sequence":"additional","affiliation":[{"name":"USAID Global Health Fellows Program, Office of Population and Reproductive Health, US Agency for International Development, Washington, DC, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Romano","sequence":"additional","affiliation":[{"name":"The Initiative for Multipurpose Prevention Technologies, Public Health Institute, Sacramento, CA, USA;"},{"name":"NWJ Group, Wayne, PA, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6472-4804","authenticated-orcid":false,"given":"Anke","family":"Hemmerling","sequence":"additional","affiliation":[{"name":"The Initiative for Multipurpose Prevention Technologies, Public Health Institute, Sacramento, CA, USA;"},{"name":"Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,9,24]]},"reference":[{"key":"e_1_3_3_2_1","unstructured":"IMPT. MPT product development database; [cited 2017 Oct 11]. Available from: http:\/\/mpts101.org\/mpt-database"},{"key":"e_1_3_3_3_1","unstructured":"Bustreo F. Ten top issues for women\u2019s health; [cited 2017 Dec 20]. Available from: www.who.int\/life-course\/news\/commentaries\/2015-intl-womens-day\/en"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1728-4465.2014.00393.x"},{"key":"e_1_3_3_5_1","unstructured":"WHO. Global Health Observatory (GHO) data: mortality and global health estimates; [cited 2017 Oct 11]. Available from: www.who.int\/gho\/mortality_burden_disease\/en"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.03.111"},{"key":"e_1_3_3_7_1","unstructured":"WHO. Sexual and reproductive health beyond 2014: equality quality of care and accountability; [cited 2017 Oct 11]. Available from: http:\/\/apps.who.int\/iris\/bitstream\/10665\/112291\/1\/WHO_RHR_14.05_eng.pdf"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/13625180802011302"},{"key":"e_1_3_3_9_1","unstructured":"IMPT. CCTN and MPT stakeholder round table on hormonal contraception (HC) in MPTs; [2015; cited 2017 Oct 11]. Available from: www.theimpt.org\/resource-results\/33-presentations\/516-women-s-health-in-women-s-hands-the-promise-of-mpts-2"},{"key":"e_1_3_3_10_1","unstructured":"IMPT. Technical meeting on hormonal contraception (HC) in MPTs; [2016; cite 2017 Oct 11]. Available from: www.theimpt.org\/resource-results\/51-technical-brief\/654-technical-meeting-on-hormonal-contraception-hc-in-mpts"},{"key":"e_1_3_3_11_1","unstructured":"CONRAD. CONRAD launches first-ever multipurpose vaginal ring clinical trial; [cited 2017 Oct 11]. Available from: www.conrad.org\/news-pressreleases-105.html"},{"key":"e_1_3_3_12_1","unstructured":"IPM. IPM advances three-month HIV prevention and contraception ring to clinical trial; [cited 2017 Oct 11]. Available from: www.ipmglobal.org\/content\/ipm-advances-three-month-hiv-prevention-and-contraception-ring-clinical-trial"},{"key":"e_1_3_3_13_1","unstructured":"IMPT. Meeting summary: technical meeting on hormonal contraceptives in MPTs. Washington DC; 2014 Sept 18\u201319; [cited 2017 Oct 11]. Available from: www.theimpt.org\/documents\/IMPT-HC-Summary-Report2014.pdf"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-014-0751-x"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-013-9861-1"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.18.2.19408"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2015.09.002"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1193748"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147743"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32832c413d"},{"key":"e_1_3_3_21_1","unstructured":"Romano J Brady M Manning J. Nonclinical development needs and regulatory requirements for multipurpose prevention technologies: a primer; [cited 2017 Dec 21]. Available from: http:\/\/citeseerx.ist.psu.edu\/viewdoc\/download?doi=10.1.1.303.3932&rep=rep1&type=pdf"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1728-4465.2014.00382.x"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/11.suppl_2.20"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2011.02.013"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f5298"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq447"},{"key":"e_1_3_3_27_1","unstructured":"Federal Register. Drug interactions with hormonal contraceptives: public health and drug development implications; public meeting; [cited 2017 Oct 11]. Available from: www.federalregister.gov\/documents\/2015\/09\/11\/2015-22949\/drug-interactions-with-hormonal-contraceptives-public-health-and-drug-development-implications"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2016.07.010"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2016.07.011"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2015.03.006"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001392"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-016-0452-7"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2016.03.010"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2011.04.009"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2017.07.168"},{"key":"e_1_3_3_36_1","first-page":"CD008452","article-title":"Hormonal contraceptives for contraception in overweight or obese women","volume":"8","author":"Lopez LM","year":"2016","unstructured":"Lopez LM, Bernholc A, Chen M, et\u00a0al. Hormonal contraceptives for contraception in overweight or obese women. Cochrane Database Syst Rev. 2016;8:CD008452.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_37_1","unstructured":"ECHO. ECHO study; [cited 2017 Oct 11]. Available from: http:\/\/echo-consortium.com\/echo-study-3"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001228"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70247-X"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1210\/er.2017-00103"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00429-6"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2012.0271"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001229"},{"key":"e_1_3_3_44_1","unstructured":"WHO. Hormonal contraceptive eligibility for women at high risk of HIV. Guidance statement; [cited 2017 Oct 11]. Available from: www.who.int\/reproductivehealth\/publications\/family_planning\/HC-and-HIV-2017\/en"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep45725"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12037"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(18)30010-9"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(17)30068-1"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000214"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1080\/15284336.2017.1379676"},{"key":"e_1_3_3_51_1","unstructured":"Brady M Park H. What regulatory guidance exists for multipurpose prevention technologies (MPTs)? A review of key guidance documents and their applicability to MPTs. [2011; cited 2017 Oct 11]. Available from: http:\/\/resource.cami-health.org\/documents\/What%20Regulatory%20Guidance%20Exists%20for%20MPTs.%20Pop%20Council.pdf"},{"key":"e_1_3_3_52_1","unstructured":"Dellplain L Young Holt B Hemmerling A et\u00a0al. Market access framework for multipurpose prevention technology (MPT) development and introduction; [2016; cited 2017 Oct 11]. Available from: www.theimpt.org\/documents\/presentations\/MarketAccessFrameworkMPT-012116.pdf"},{"key":"e_1_3_3_53_1","unstructured":"Dellplain L Thomas V Russell E et\u00a0al. Laying the groundwork for a strategic evaluation framework (SEF) for HIV prevention and MPT product development; [cited 2017 Oct 11]. Available from: www.theimpt.org\/documents\/breif\/IMPT_Activity1Report_Final122116.pdf"},{"key":"e_1_3_3_54_1","unstructured":"IMPT. Strategic evaluation framework (SEF) for MPTs: strategic target profile context summaries; [cited 2017 Oct 11]. Available from: www.theimpt.org\/documents\/reports\/SEF-NextSteps-Report_FY17.pdf"},{"key":"e_1_3_3_55_1","unstructured":"DiLiberti C Dorflinger L Romano J. Bioavailability\/bioequivalence strategies for MPTs \u2013 feasibility and risks; [cited 2018 Jan 28]. Available from: www.theimpt.org\/multi-media\/Bioavailability_Bioequivalence%20Webinar%20Audio_26%20Jan%202017.mp4"},{"key":"e_1_3_3_56_1","unstructured":"USAID. Idea to impact: a guide to introduction and scale; [2015; cited 2017 Oct 11]. Available from: www.usaid.gov\/cii\/guide-introduction-and-scale"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2013.09.019"},{"key":"e_1_3_3_58_1","unstructured":"IMPT. IMPT annual report; [2016; cited 2018 Feb 21]. Available from: www.theimpt.org\/resource-results\/70-reports-annual\/1053-2016-impt-annual-report2"},{"key":"e_1_3_3_59_1","unstructured":"NIH. Next generation multipurpose prevention technologies (NGM); [cited 2017 Nov 11]. Available from: https:\/\/grants.nih.gov\/grants\/guide\/rfa-files\/RFA-AI-17-028.html#CT"},{"key":"e_1_3_3_60_1","unstructured":"NIH. Advancing the science of multipurpose technology for the prevention of HIV and unintended pregnancy (R43\/R44); [cited 2017 Nov 11]. Available from: https:\/\/grants.nih.gov\/grants\/guide\/rfa-files\/RFA-HD-18-102.html"},{"key":"e_1_3_3_61_1","unstructured":"NIH. Contraception research centers program (U54); [cited 2017 Nov 11]. Available from: https:\/\/grants.nih.gov\/grants\/guide\/rfa-files\/RFA-HD-18-035.html"},{"key":"e_1_3_3_62_1","unstructured":"CEPI. Mission; [cited 2018 Jul 9]. Available from: http:\/\/cepi.net\/mission"},{"key":"e_1_3_3_63_1","unstructured":"Boonstra H Young Holt B. Multipurpose prevention technologies hold great promise but more US investment is needed; [2015; cited 2017 Dec 20]. Available from: http:\/\/thehill.com\/blogs\/congress-blog\/healthcare\/261512-multipurpose-prevention-technologies-hold-great-promise-but"}],"container-title":["The European Journal of Contraception & Reproductive Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13625187.2018.1508650","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T14:45:24Z","timestamp":1708526724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13625187.2018.1508650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,3]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9,3]]}},"alternative-id":["10.1080\/13625187.2018.1508650"],"URL":"https:\/\/doi.org\/10.1080\/13625187.2018.1508650","relation":{},"ISSN":["1362-5187","1473-0782"],"issn-type":[{"value":"1362-5187","type":"print"},{"value":"1473-0782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iejc20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iejc20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-05-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-31","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}